Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of April 3, 2025 • 7:31 PM ET

Date/Time Source News Release
03/31/2025 05:00 PM EDT GlobeNewswire Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights
02/04/2025 12:24 PM EST GlobeNewswire Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering
12/03/2024 08:30 AM EST GlobeNewswire GLUCOTRACK ANNOUNCES START OF ENROLLMENT FOR HUMAN CLINICAL STUDY OF CONTINUOUS BLOOD GLUCOSE MONITOR
11/14/2024 04:30 PM EST GlobeNewswire Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt
11/13/2024 09:00 AM EST GlobeNewswire Glucotrack, Inc. Announces Pricing of $10.0 Million Public Offering
10/22/2024 09:00 AM EDT GlobeNewswire GLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE
10/01/2024 09:00 AM EDT GlobeNewswire GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING
09/03/2024 09:00 AM EDT GlobeNewswire JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS
08/27/2024 09:00 AM EDT GlobeNewswire GLUCOTRACK ANNOUNCES NEW VICE PRESIDENT OF CLINICAL OPERATIONS
08/15/2024 09:00 AM EDT GlobeNewswire Glucotrack's Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference
Page

Additional News

As of April 3, 2025 • 7:31 PM ET

Date/Time Source News Release
08/12/2021 09:46 AM EDT SeekingAlpha Integrity Applications implements 1-for-13 reverse split
09/14/2020 09:00 AM EDT Thomson Reuters ONE Integrity Applications Provides Commercial Update
Page
  • 1

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.